Is liver disease a threat to patients with metabolic disorders?
about
Effect of Intramuscular Adipose Tissue Content on Prognosis in Patients Undergoing Hepatocellular Carcinoma Resection.Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.Prevalence of elevated liver enzymes in Type 2 diabetes mellitus and its association with the metabolic syndrome.Impact of postoperative changes in sarcopenic factors on outcomes after hepatectomy for hepatocellular carcinoma.Mitigating the scourge of non-alcoholic fatty liver disease in Ghana.
P2860
Is liver disease a threat to patients with metabolic disorders?
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Is liver disease a threat to patients with metabolic disorders?
@ast
Is liver disease a threat to patients with metabolic disorders?
@en
type
label
Is liver disease a threat to patients with metabolic disorders?
@ast
Is liver disease a threat to patients with metabolic disorders?
@en
prefLabel
Is liver disease a threat to patients with metabolic disorders?
@ast
Is liver disease a threat to patients with metabolic disorders?
@en
P2860
P1433
P1476
Is liver disease a threat to patients with metabolic disorders?
@en
P2093
Gabriele Forlani
P2860
P304
P356
10.1080/07853890510011445
P407
P577
2005-01-01T00:00:00Z